# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-109698
Filing Date
2025-11-12
Accepted
2025-11-12 07:00:44
Documents
53
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acxp-20250930x10q.htm iXBRL | 10-Q | 1734294
2 | EX-31.1 | acxp-20250930xex31d1.htm | EX-31.1 | 12539
3 | EX-31.2 | acxp-20250930xex31d2.htm | EX-31.2 | 12544
4 | EX-32.1 | acxp-20250930xex32d1.htm | EX-32.1 | 5416
5 | EX-32.2 | acxp-20250930xex32d2.htm | EX-32.2 | 5454
| Complete submission text file | 0001104659-25-109698.txt |  | 5971754

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | acxp-20250930.xsd | EX-101.SCH | 42687
7 | EX-101.CAL | acxp-20250930_cal.xml | EX-101.CAL | 20543
8 | EX-101.DEF | acxp-20250930_def.xml | EX-101.DEF | 143776
9 | EX-101.LAB | acxp-20250930_lab.xml | EX-101.LAB | 361621
10 | EX-101.PRE | acxp-20250930_pre.xml | EX-101.PRE | 263447
56 | EXTRACTED XBRL INSTANCE DOCUMENT | acxp-20250930x10q_htm.xml | XML | 784592

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40536 | Film No.: 251468637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)